BHCM
MLAB icon

Brevan Howard Capital Management’s Mesa Laboratories MLAB Stock Holding History

Brevan Howard Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,977
Closed -$401K – 2108
2025
Q3 		$401K Buy
5,977
+3,678
+160% +$265K ﹤0.01% 1402
2025
Q2 		$217K Buy
+2,299
New +$252K ﹤0.01% 1683

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Brevan Howard Capital Management's MLAB Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Mesa Laboratories (MLAB) in Q4 2025, closing a stake of 5,977 shares — an estimated $401K sold.

Brevan Howard Capital Management first reported a position in MLAB in Q2 2025 and held it in 2 quarters. The position peaked at $401K in Q3 2025. 159 funds tracked by Wall St. Rank hold MLAB as of Q4 2025.

  • Brevan Howard Capital Management reported no remaining Mesa Laboratories position as of Q4 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 5,977 Mesa Laboratories shares in Q4 2025, an estimated $401K.
  • Brevan Howard Capital Management first reported a position in Mesa Laboratories in Q2 2025 and held it in 2 quarters.
  • Brevan Howard Capital Management's Mesa Laboratories position peaked at $401K in Q3 2025.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.